Thiophene Carboxylic Acid

Thiophene Carboxylic Acid

SCHEMBL6711005

N#Cc1ccc(C(=O)N(Cc2cnc[nH]2)c2ccc(N3CCN(C(=O)c4ccc(Cl)s4)CC3)cc2)cc1.O=C(O)c1cccs1

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.41
KCNA5 P22460 1/20 0.36
MAPKAPK2 P49137 1/20 0.36
PDK1 Q15118 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6712564 0.93 MAPT (0.43) MAPTMAPKAPK2PDK1
SCHEMBL7089951 0.81
SCHEMBL6715064 0.79 MAPT (0.45) MAPT
SCHEMBL6712631 0.78 ALDH1A1 (0.52) MAPT
SCHEMBL6708741 0.77 FNTA (0.48) MAPT
SCHEMBL6708786 0.76 FNTA (0.48) MAPT
SCHEMBL6708721 0.75 FNTA (0.48)
SCHEMBL6712759 0.74 FNTA (0.45) MAPT
SCHEMBL6711360 0.74 FNTA (0.45)
SCHEMBL6708705 0.74 FNTA (0.45) MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040092524-A1 Novel aminophenyl piperazine or aminophenyl piperidine derivatives inhibiting prenyl transferase proteins and method for preparing same PIERRE FABRE MEDICAMENT (FR) 2004-05-13 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040092524-A1 Novel aminophenyl piperazine or aminophenyl piperidine derivatives inhibiting prenyl transferase proteins and method for preparing same CBR3, CBR1, HCCS MAPT 4753/4885KCNA5 2060/4885MAPKAPK2 3489/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.